Wolverine Trading, LLC Protalix Bio Therapeutics, Inc. Put Options Transaction History

Wolverine Trading, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 Aug 23, 2023	BUY	$2.0 - $3.36 $30,200 - $50,736	15,100 New	15,100 $30,000
Q1 2022 May 16, 2022	SELL	$0.81 - $1.17 $8,100 - $11,700	-10,000 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$0.81 - $1.33 $8,100 - $13,300	-10,000 Reduced 50.0%	10,000 $9,000
Q3 2021 Nov 12, 2021	SELL	$1.31 - $1.87 $34,977 - $49,929	-26,700 Reduced 57.17%	20,000 $27,000
Q2 2021 Aug 06, 2021	BUY	$1.86 - $6.22 $30,690 - $102,630	16,500 Added 54.64%	46,700 $89,000
Q1 2021 May 14, 2021	BUY	$3.58 - $6.45 $108,116 - $194,790	30,200 New	30,200 $136,000

3.58M

61.1K

36.2K

Ticker PLX
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,753,400
Market Cap $91M
Description
Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.